Biotech names led the after-hours rally, with SOPHiA GENETICS (SOPH) jumping nearly 10% and SELLAS Life Sciences (SLS) gaining 3.5% after announcing upcoming ESMO 2025 data on its CDK9 inhibitor.
Shares of SELLAS Life Sciences Group Inc. (SLS) are up 3.50% at $2.07 in the extended trading, after the company announced that preclinical efficacy of its highly selective CDK9 inhibitor, SLS009 (tambiciclib), as a monotherapy and in combination with venetoclax in T-cell prolymphocytic leukemia (T-PLL), will be presented at the European Society for Medical Oncology (ESMO) Congress 2025, being held October 17 - 21, 2025, in Berlin, Germany.
SOPHiA GENETICS SA (SOPH) up 9.90% at $4.44 Ironwood Pharmaceuticals Inc. (IRWD) up 6.76% at $1.58Spectral AI Inc. (MDAI) up 8.60% at $2.40Adverum Biotechnologies Inc. (ADVM) up 7.21% at $4.46 AC Immune SA (ACIU) up 6.26% at $3.69Senti Biosciences Inc. (SNTI) up 4.76% at $1.76Vivos Therapeutics Inc. (VVOS) up 4.10% at $3.30Mangoceuticals Inc. (MGRX) up 2.77% at $2.60InflaRx N.V. (IFRX) up 3.20% at $1.29Talkspace, Inc. (TALK) up 6.16% at $3.10MDxHealth SA (MDXH) up 3.81% at $4.36Acrivon Therapeutics Inc. (ACRV) up 3.39% at $1.83Gain Therapeutics Inc. (GANX) up 3.16% at $1.96Alpha Teknova Inc. (TKNO) up 2.20% at $5.12Tenaya Therapeutics Inc. (TNYA) up 7.58% at $2.13Eledon Pharmaceuticals Inc. (ELDN) up 5.52% at $2.87Fate Therapeutics Inc. (FATE) up 3.60% at $1.44Adicet Bio Inc. (ACET) up 7.22% at $1.05Tectonic Therapeutic Inc. (TECX) up 4.10% at $16.75Galecto Inc. (GLTO) up 4.55% at $13.33Adagene Inc. (ADAG) up 2.09% at $1.95Skye Bioscience Inc. (SKYE) up 3.65% at $1.56Ginkgo Bioworks Holdings Inc. (DNA) up 3.88% at $13.67LENZ Therapeutics Inc. (LENZ) up 3.83% at $40.09Gossamer Bio Inc. (GOSS) up 2.46% at $2.50
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.